lignans and Respiratory-Tract-Diseases

lignans has been researched along with Respiratory-Tract-Diseases* in 2 studies

Other Studies

2 other study(ies) available for lignans and Respiratory-Tract-Diseases

ArticleYear
Magnolia officinalis L. bark extract and respiratory diseases: From traditional Chinese medicine to western medicine via network target.
    Phytotherapy research : PTR, 2023, Volume: 37, Issue:7

    The understanding of the use of Magnolia officinalis L. (Magnoliaceae) as a possible dietary supplement for supporting the treatment of airway pathologies might be of clinical interest. Two commercially available bark extracts (M. officinalis extract [MOE]) were characterized by quantitation in honokiol and magnolol content by means of high-performance liquid chromatography with UV detection. MOE effects, as well as those of the reference compounds per se, on some targets connected to airway pathologies (antibacterial- and lung and trachea relaxing- activities) were investigated. Results showed that MOE possessed interesting antibacterial activity against Staphylococcus aureus, Pseudomonas aeruginosa, and Streptococcus pneumoniae. This was accompanied by a spasmolytic and antispasmodic activity, possibly owing to its ability to concurrently modulate different targets such as H

    Topics: Biphenyl Compounds; Humans; Lignans; Magnolia; Medicine, Chinese Traditional; Plant Bark; Plant Extracts; Respiratory Tract Diseases

2023
Arctigenin exhibits relaxation effect on bronchus by affecting transmembrane flow of calcium.
    Biological trace element research, 2013, Volume: 156, Issue:1-3

    Arctigenin, a lignan extract from Arctium lappa (L.), exhibits anti-inflammation, antioxidation, vasodilator effects, etc. However, the effects of arctigenin on bronchus relaxation are not well investigated. This study aimed to investigate how arctigenin regulates bronchus tone and calcium ion (Ca(2+)) flow. Trachea strips of guinea pigs were prepared for testing the relaxation effect of arctigenin to acetylcholine, histamine, KCl, and CaCl2, respectively. Furthermore, L-type calcium channel currents were detected by patch-clamp, and intracellular Ca(2+) concentration was detected by confocal microscopy. The results showed that arctigenin exhibited relaxation effect on tracheae to different constrictors, and this was related to decreasing cytoplasmic Ca(2+) concentration by inhibiting Ca(2+) influx partly through L-type calcium channel as well as promoting Ca(2+) efflux. In summary, this study provides new insight into the mechanisms by which arctigenin exhibits relaxation effect on bronchus and suggests its potential use for airway disease therapy.

    Topics: Animals; Arctium; Bronchi; Bronchodilator Agents; Calcium; Calcium Channels, L-Type; Cell Membrane; Female; Furans; Guinea Pigs; Ion Transport; Lignans; Male; Respiratory Tract Diseases

2013